69123-52-0

Basic information

• Product Name: ethyl 4-{[(6-methoxy-1,3-benzothiazol-2-yl)carbamoyl]amino}benzoate
• CAS NO: 69123-52-0
• Molecular Formula: C₁₈H₁₇N₃O₄S
• Molecular Weight: 371.4103
• Mol File: 69123-52-0.mol

Chemical Properties

• Density: 1.401g/cm³
• Refractive Index: 1.7
• CAS DataBase Reference: ethyl 4-{[(6-methoxy-1,3-benzothiazol-2-yl)carbamoyl]amino}benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 4-{[(6-methoxy-1,3-benzothiazol-2-yl)carbamoyl]amino}benzoate(69123-52-0)
• EPA Substance Registry System: ethyl 4-{[(6-methoxy-1,3-benzothiazol-2-yl)carbamoyl]amino}benzoate(69123-52-0)

Safety Data

• Hazardous Substances Data: 69123-52-0(Hazardous Substances Data)

Upstream product

• 1747-60-0 6-methoxybenzothiazol-2-ylamine 
• 30806-83-8 p-ethoxycarbonylphenyl isocyanate 

Downstream Products

• 866001-38-9 4-(3-(6-methoxybenzo[d]thiazol-2-yl)ureido)benzoic acid 

Relevant articles and documents

Design and synthesis of conformationally constraint Dyrk1A inhibitors by creating an intramolecular H-bond involving a benzothiazole core

We present the development of conformationally pre-organised Dyrk1A inhibitors based on the hydroxybenzothiazole urea scaffold. The modifications introduced to the discovered hit (AHS-211) proved the crucial role of the urea linker to preserve the bioacti

INHIBITORS OF HISTONE DEACETYLASE

The invention relates to a series of compounds useful for inhibiting histone deacetylase (HDAC) enzymatic activity. The invention also provides a method for inhibiting histone descetylase in a cell using said compounds as well as a method for treating cell proliferative diseases and conditions using said HDAC inhibitors. Further, the invention provides pharmaceutical compositions comprising the HDAC inhibiting compounds and a pharmaceutically acceptable carrier.